National Health Investors (NYSE:NHI) Upgraded by ValuEngine to Hold

Share on StockTwits

ValuEngine upgraded shares of National Health Investors (NYSE:NHI) from a sell rating to a hold rating in a research note released on Friday, ValuEngine reports.

Separately, Zacks Investment Research raised National Health Investors from a sell rating to a hold rating in a research report on Thursday, October 24th. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $79.60.

NYSE:NHI traded up $0.76 during midday trading on Friday, hitting $84.95. 94,987 shares of the company traded hands, compared to its average volume of 172,694. The firm’s fifty day moving average is $83.25 and its 200-day moving average is $80.20. The firm has a market capitalization of $3.65 billion, a P/E ratio of 15.50, a P/E/G ratio of 3.85 and a beta of 0.29. The company has a current ratio of 14.42, a quick ratio of 14.42 and a debt-to-equity ratio of 1.04. National Health Investors has a 12-month low of $72.15 and a 12-month high of $86.54.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Thursday, August 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.37 by ($0.45). The business had revenue of $78.10 million during the quarter, compared to the consensus estimate of $77.64 million. National Health Investors had a net margin of 50.71% and a return on equity of 11.00%. The business’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $1.38 EPS. On average, research analysts expect that National Health Investors will post 5.49 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Monday, September 30th will be given a $1.05 dividend. This represents a $4.20 annualized dividend and a yield of 4.94%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio (DPR) is presently 76.64%.

In other National Health Investors news, CIO Kevin Carlton Pascoe sold 900 shares of the company’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total value of $74,214.00. Following the transaction, the executive now owns 27,826 shares of the company’s stock, valued at approximately $2,294,531.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 5.11% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of National Health Investors by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 6,700,053 shares of the real estate investment trust’s stock worth $522,805,000 after buying an additional 83,616 shares in the last quarter. Northern Trust Corp grew its position in shares of National Health Investors by 9.2% during the 2nd quarter. Northern Trust Corp now owns 1,040,634 shares of the real estate investment trust’s stock worth $81,201,000 after buying an additional 87,553 shares in the last quarter. Hamlin Capital Management LLC grew its position in shares of National Health Investors by 32.9% during the 2nd quarter. Hamlin Capital Management LLC now owns 716,556 shares of the real estate investment trust’s stock worth $55,913,000 after buying an additional 177,580 shares in the last quarter. Bank of America Corp DE grew its position in shares of National Health Investors by 15.7% during the 2nd quarter. Bank of America Corp DE now owns 639,607 shares of the real estate investment trust’s stock worth $49,909,000 after buying an additional 86,995 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its position in shares of National Health Investors by 6,428.7% during the 2nd quarter. Nuveen Asset Management LLC now owns 558,527 shares of the real estate investment trust’s stock worth $43,582,000 after buying an additional 549,972 shares in the last quarter. 69.62% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: Commodities

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

$745.53 Million in Sales Expected for Toro Co  This Quarter
$745.53 Million in Sales Expected for Toro Co This Quarter
Zacks: Brokerages Expect Piedmont Office Realty Trust, Inc.  to Announce $0.45 Earnings Per Share
Zacks: Brokerages Expect Piedmont Office Realty Trust, Inc. to Announce $0.45 Earnings Per Share
-$0.42 EPS Expected for Iovance Biotherapeutics Inc  This Quarter
-$0.42 EPS Expected for Iovance Biotherapeutics Inc This Quarter
Xcel Energy Inc  Expected to Post Quarterly Sales of $3.07 Billion
Xcel Energy Inc Expected to Post Quarterly Sales of $3.07 Billion
Wanchain Hits One Day Volume of $956,588.00
Wanchain Hits One Day Volume of $956,588.00
PrimeStone Reaches 1-Day Trading Volume of $20.00
PrimeStone Reaches 1-Day Trading Volume of $20.00


© 2006-2019 Ticker Report